Loading...
BioLife Solutions Community
NasdaqCM:BLFS Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
Community Investing Ideas
Cell And Gene Therapies Will Unlock Biopreservation Potential
Key Takeaways Cross-selling of integrated products and new technology adoption are increasing customer retention and boosting both revenue per dose and overall margins. Strategic acquisitions and a growing regenerative medicine market position BioLife for sustained revenue growth and strengthened market leadership.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$31.3
23.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
19.95% p.a.
Profit Margin
20.59%
Future PE
60.33x
Share price in 2028
US$37.97